ClariVest Asset Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-34
Closed 737
2022
Q3
$0 Hold
34
﹤0.01% 747
2022
Q2
$0 Hold
34
﹤0.01% 764
2022
Q1
$1K Hold
34
﹤0.01% 665
2021
Q4
$0 Hold
34
﹤0.01% 803
2021
Q3
$0 Hold
34
﹤0.01% 815
2021
Q2
$1K Hold
34
﹤0.01% 707
2021
Q1
$1K Hold
34
﹤0.01% 696
2020
Q4
$1K Hold
34
﹤0.01% 721
2020
Q3
$0 Sell
34
-24,000
-100% -$352K ﹤0.01% 836
2020
Q2
$346K Sell
24,034
-14,000
-37% -$184K 0.01% 457
2020
Q1
$415K Sell
38,034
-2,400
-6% -$44.3K 0.01% 418
2019
Q4
$863K Buy
+40,434
New +$905K 0.02% 372
2016
Q2
Sell
-21,800
Closed -$438K 677
2016
Q1
$438K Buy
+21,800
New +$418K 0.01% 367

Other funds holding SBRA

ClariVest Asset Management's SBRA Position: Q4 2022 in Review

ClariVest Asset Management sold out of Sabra Healthcare REIT (SBRA) in Q4 2022, closing a stake of 34 shares.

ClariVest Asset Management first reported a position in SBRA in Q1 2016 and held it in 13 quarters. The position peaked at $863K in Q4 2019. 327 funds tracked by Wall St. Rank hold SBRA as of Q4 2022.

  • ClariVest Asset Management reported no remaining Sabra Healthcare REIT position as of Q4 2022 after selling out during the quarter.
  • ClariVest Asset Management sold 34 Sabra Healthcare REIT shares in Q4 2022.
  • ClariVest Asset Management first reported a position in Sabra Healthcare REIT in Q1 2016 and held it in 13 quarters.
  • ClariVest Asset Management's Sabra Healthcare REIT position peaked at $863K in Q4 2019.
  • 327 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2022.

Based on ClariVest Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.